Pharmacological Reviews
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     



0031-6997/05/5703-289-298$7.00
Pharmacol Rev 57:289-298, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prinster, S. C.
Right arrow Articles by Hall, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prinster, S. C.
Right arrow Articles by Hall, R. A.

Article

Heterodimerization of G Protein-Coupled Receptors: Specificity and Functional Significance

Steven C. Prinster, Chris Hague and Randy A. Hall

Department of Pharmacology, Emory University School of Medicine, Atlanta Georgia

Abstract
I. Introduction
    A. GABAB Receptors
    B. Taste Receptors
    C. Adrenergic Receptors
    D. Opioid Receptors
    E. Somatostatin Receptors
    F. Purinergic Receptors
    G. Olfactory Receptors
    H. Vasopressin, Oxytocin, and Other Receptors
II. Clinical Significance of GPCR Heterodimerization
III. Conclusions
Abstract

G protein-coupled receptors (GPCRs) are cell surface receptors that mediate physiological responses to a diverse array of stimuli. GPCRs have traditionally been thought to act as monomers, but recent evidence suggests that GPCRs may form dimers (or higher-order oligomers) as part of their normal trafficking and function. In fact, certain GPCRs seem to have a strict requirement for heterodimerization to attain proper surface expression and functional activity. Even those GPCRs that do not absolutely require heterodimerization may still specifically associate with other GPCR subtypes, sometimes resulting in dramatic effects on receptor pharmacology, signaling, and/or internalization. Understanding the specificity and functional significance of GPCR heterodimerization is of tremendous clinical importance since GPCRs are the molecular targets for numerous therapeutic drugs.


Address correspondence to: Randy A. Hall, Department of Pharmacology, Emory University School of Medicine, 5113 Rollins Research Center, 1510 Clifton Rd., Atlanta, GA 30322. E-mail: rhall{at}pharm.emory.edu




This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
J. S. Davies, P. Kotokorpi, S. R. Eccles, S. K. Barnes, P. F. Tokarczuk, S. K. Allen, H. S. Whitworth, I. A. Guschina, B. A. J. Evans, A. Mode, et al.
Ghrelin Induces Abdominal Obesity Via GHS-R-Dependent Lipid Retention
Mol. Endocrinol., June 1, 2009; 23(6): 914 - 924.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. J. Copik, C. Ma, A. Kosaka, S. Sahdeo, A. Trane, H. Ho, P. S. Dietrich, H. Yu, A. P. D. W. Ford, D. Button, et al.
Facilitatory Interplay in {alpha}1a and {beta}2 Adrenoceptor Function Reveals a Non-Gq Signaling Mode: Implications for Diversification of Intracellular Signal Transduction
Mol. Pharmacol., March 1, 2009; 75(3): 713 - 728.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
K. Fuxe, D. Marcellino, D. Guidolin, A. S. Woods, and L. F. Agnati
Heterodimers and Receptor Mosaics of Different Types of G-Protein-Coupled Receptors
Physiology, December 1, 2008; 23(6): 322 - 332.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. Grant, H. Alturaihi, P. Jaquet, B. Collier, and U. Kumar
Cell Growth Inhibition and Functioning of Human Somatostatin Receptor Type 2 Are Modulated by Receptor Heterodimerization
Mol. Endocrinol., October 1, 2008; 22(10): 2278 - 2292.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
P. Harrison, L. Lyon, L. Sartorius, P. Burnet, and T. Lane
Review: The group II metabotropic glutamate receptor 3 (mGluR3, mGlu3, GRM3): expression, function and involvement in schizophrenia
J Psychopharmacol, May 1, 2008; 22(3): 308 - 322.
[Abstract] [PDF]


Home page
Physiol. Rev.Home page
G. S. Lynch and J. G. Ryall
Role of {beta}-Adrenoceptor Signaling in Skeletal Muscle: Implications for Muscle Wasting and Disease
Physiol Rev, April 1, 2008; 88(2): 729 - 767.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
L. Szidonya, M. Cserzo, and L. Hunyady
Dimerization and oligomerization of G-protein-coupled receptors: debated structures with established and emerging functions
J. Endocrinol., March 1, 2008; 196(3): 435 - 453.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Nomura, Y. Suzuki, A. Kakizuka, and H. Jingami
Direct Detection of the Interaction between Recombinant Soluble Extracellular Regions in the Heterodimeric Metabotropic {gamma}-Aminobutyric Acid Receptor
J. Biol. Chem., February 22, 2008; 283(8): 4665 - 4673.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. R. Whorton, B. Jastrzebska, P. S.-H. Park, D. Fotiadis, A. Engel, K. Palczewski, and R. K. Sunahara
Efficient Coupling of Transducin to Monomeric Rhodopsin in a Phospholipid Bilayer
J. Biol. Chem., February 15, 2008; 283(7): 4387 - 4394.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Zeng, I. Armando, Y. Luo, G. M. Eisner, R. A. Felder, and P. A. Jose
Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice
Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H551 - H569.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
V. Vallon
P2 receptors in the regulation of renal transport mechanisms
Am J Physiol Renal Physiol, January 1, 2008; 294(1): F10 - F27.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Mogi, M. Iwai, and M. Horiuchi
Emerging Concepts of Regulation of Angiotensin II Receptors: New Players and Targets for Traditional Receptors
Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2532 - 2539.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. N. Nikolov and T. T. Ivanova-Nikolova
Dynamic Integration of {alpha}-Adrenergic and Cholinergic Signals in the Atria: ROLE OF G PROTEIN-REGULATED INWARDLY RECTIFYING K+ CHANNELS
J. Biol. Chem., September 28, 2007; 282(39): 28669 - 28682.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Li, P. I. Poulikakos, Z. Dai, J. R. Testa, D. J. E. Callaway, and Z. Bu
Protein Kinase C Phosphorylation Disrupts Na+/H+ Exchanger Regulatory Factor 1 Autoinhibition and Promotes Cystic Fibrosis Transmembrane Conductance Regulator Macromolecular Assembly
J. Biol. Chem., September 14, 2007; 282(37): 27086 - 27099.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. A. Fenton, L. Brond, S. Nielsen, and J. Praetorius
Cellular and subcellular distribution of the type-2 vasopressin receptor in the kidney
Am J Physiol Renal Physiol, September 1, 2007; 293(3): F748 - F760.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. A. Johnston and D. P. Siderovski
Receptor-Mediated Activation of Heterotrimeric G-Proteins: Current Structural Insights
Mol. Pharmacol., August 1, 2007; 72(2): 219 - 230.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. M. Lunzer and P. S. Portoghese
Selectivity of {delta}- and {kappa}-Opioid Ligands Depends on the Route of Central Administration in Mice
J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 166 - 171.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
G. Burnstock
Physiology and Pathophysiology of Purinergic Neurotransmission
Physiol Rev, April 1, 2007; 87(2): 659 - 797.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
D. Ferone, A. Saveanu, M. D Culler, M. Arvigo, A. Rebora, F. Gatto, F. Minuto, and P. Jaquet
Novel chimeric somatostatin analogs: facts and perspectives
Eur. J. Endocrinol., April 1, 2007; 156(suppl_1): S23 - S28.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
J.-P. Pin, R. Neubig, M. Bouvier, L. Devi, M. Filizola, J. A. Javitch, M. J. Lohse, G. Milligan, K. Palczewski, M. Parmentier, et al.
International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the Recognition and Nomenclature of G Protein-Coupled Receptor Heteromultimers
Pharmacol. Rev., March 1, 2007; 59(1): 5 - 13.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. C. Prinster, T. G. Holmqvist, and R. A. Hall
{alpha}2C-Adrenergic Receptors Exhibit Enhanced Surface Expression and Signaling upon Association with beta2-Adrenergic Receptors
J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 974 - 981.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. A. Snook, G. Milligan, B. L. Kieffer, and D. Massotte
{micro}-{delta} Opioid Receptor Functional Interaction: Insight Using Receptor-G Protein Fusions
J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 683 - 690.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Kota, P. J. Reeves, U. L. RajBhandary, and H. G. Khorana
Opsin is present as dimers in COS1 cells: Identification of amino acids at the dimeric interface
PNAS, February 28, 2006; 103(9): 3054 - 3059.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Hague, S. E. Lee, Z. Chen, S. C. Prinster, R. A. Hall, and K. P. Minneman
Heterodimers of {alpha}1B- and {alpha}1D-Adrenergic Receptors Form a Single Functional Entity
Mol. Pharmacol., January 1, 2006; 69(1): 45 - 55.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition
Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics